ArticleAME case reports2026
The spectrum of legionnaires' disease: a case series illustrating clinical diversity and outcomes.
Article in AME case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Case Description: We present five patients with confirmed Legionnaires' disease in a community hospital setting. Patients' ages ranged from 38 to 83 years old with varied comorbidities. Clinical presentations included respiratory symptoms (cough, dyspnea), systemic manifestations (fever, fatigue, malaise), and extrapulmonary features (diarrhea, hyponatremia). Hyponatremia was present in 40% of the cohort. Chest imaging revealed unilateral or bilateral infiltrates. Diagnosis was confirmed via urinary antigen testing detecting Conclusions: This case series reinforces the variable clinical presentation of Legionnaires' disease and emphasizes the critical importance of clinical suspicion in patients with atypical pneumonia, particularly those with risk factors including advanced age, comorbidities, or exposure to aerosolized water sources. Early recognition and appropriate antimicrobial therapy are essential to reduce morbidity and mortality.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.